US President's Malaria Initiative for States Project
The US Agency for International Development (USAID) issued an Indefinite Delivery Indefinite Quantity (IDIQ) Contract for the US President's Malaria Initiative for States (PMI-S) Project to MSH on June 29, 2018. This project will contribute to the vision of Nigeria’s National Malaria Elimination Program of having “a malaria-free Nigeria”, and the PMI 2015–2020 goal of reducing malaria-associated mortality by reducing the incidence of severe malaria and associated complications. The goal of PMI-S is to contribute to the reduction of all causes of under-five and maternal mortality by delivering quality services for the management of malaria and its complications and the prevention of malaria during pregnancy.
The four main objectives of PMI-S are to:
- Increase malaria test rates from 30% (2014 HMIS) to 85%
- Provide appropriate malaria treatment according to the national treatment guidelines in at least 85% of parasitological confirmed malaria cases
- Increase the number of pregnant women receiving three or more doses of intermittent preventive treatment in pregnancy (IPTp) through Directly Observed Therapy with sulfadoxine-pyrimethamine or any other World Health Organization-approved drugs at antenatal clinics or at the community level through community IPTp from the 2013 NDHS level of 5.8% to at least 80%
- Increase access to appropriate treatment of malaria, pneumonia, and diarrhea by 50% over 2015 levels in selected local government authorities through the integrated community case management approach